Leukocytosis and enhanced susceptibility to endotoxemia but not atherosclerosis in adrenalectomized APOE knockout mice

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Hoekstra, Menno ^a   Frodermann, Vanessa ^a   Van Den Aardweg, Tim ^a   Van Der Sluis, Ronald J ^a   Kuiper, Johan ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CORTICOSTERONE; L SELECTIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; ENDOTOXEMIA; KNOCKOUT MOUSE; LEUKOCYTOSIS; LIPOPROTEIN BLOOD LEVEL; LYMPHOCYTE COUNT; MOUSE; NONHUMAN; SPLEEN WEIGHT; THYMOCYTE;

ADRENALECTOMY; ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ENDOTOXEMIA; ERYTHROCYTE INDICES; FEMALE; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIPOPROTEINS; LIVER; MALE; MICE; MICE, KNOCKOUT;

EID: 84892982653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080441     Document Type: Article

References (36)

1. Lammers B, Out R, Hildebrand RB, Quinn CM, Williamson D et al. (2009) Independent protective roles for macrophage Abcg1 and Apoe in the atherosclerotic lesion development. Atherosclerosis 205: 420-426. doi:10.1016/j.atherosclerosis.2009.01.017. PubMed: 19217108.
2. Davignon J (2005) Apolipoprotein E and atherosclerosis: beyond lipid effect. Arterioscler Thromb Vasc Biol 25: 267-269. PubMed: 15681305.
3. Ishigami M, Swertfeger DK, Hui MS, Granholm NA, Hui DY (2000) Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 20: 1020-1026. doi:10.1161/01.ATV.20.4.1020. PubMed: 10764667. (Pubitemid 30207576)
4. Mahley RW, Ji ZS (1990) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40: 1-16. PubMed: 9869645.
5. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471. doi:10.1126/science.1411543. PubMed: 1411543.
6. de Bont N, Netea MG, Demacker PN, Verschueren I, Kullberg BJ et al. (1999) Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 40: 680-685. PubMed: 10191292.
7. Roselaar SE, Daugherty A (1998) Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res 39: 1740-1743. PubMed: 9741685. (Pubitemid 28411160)
8. Baschant U, Tuckermann J (2010) The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol 120: 69-75. doi:10.1016/j.jsbmb.2010.03.058. PubMed: 20346397.
9. van der Sluis RJ, van Puijvelde GH, Van Berkel TJ, Hoekstra M (2012) Adrenalectomy stimulates the formation of initial atherosclerotic lesions: reversal by adrenal transplantation. Atherosclerosis 221: 76-83. doi:10.1016/j.atherosclerosis.2011.12.022. PubMed: 22236481.
10. Raber J, Akana SF, Bhatnagar S, Dallman MF, Wong D et al. (2000) Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice: possible role in behavioral and metabolic alterations. J Neurosci 20: 2064-2071. PubMed: 10684907. (Pubitemid 30220403)
11. Grootendorst J, de Kloet ER, Dalm S, Oitzl MS (2001) Reversal of cognitive deficit of apolipoprotein E knockout mice after repeated exposure to a common environmental experience. Neuroscience 108: 237-247. doi:10.1016/S0306-4522(01)00412-2. PubMed: 11734357. (Pubitemid 33152965)
12. Romeo RD, Kaplowitz ET, Ho A, Franco D (2013) The influence of puberty on stress reactivity and forebrain glucocorticoid receptor levels in inbred and outbred strains of male and female mice. Psychoneuroendocrinology 38: 592-596. doi:10.1016/j.psyneuen.2012.07.019. PubMed: 22917621.
13. Goel N, Bale TL (2010) Sex differences in the serotonergic influence on the hypothalamic-pituitary-adrenal stress axis. Endocrinology 151: 1784-1794. doi:10.1210/en.2009-1180. PubMed: 20185764.
14. Caligiuri G, Nicoletti A, Zhou X, Törnberg I, Hansson GK (1999) Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis 145: 301-308. doi:10.1016/S0021-9150(99)00081-7. PubMed: 10488957. (Pubitemid 29359138)
15. Spinedi E, Suescun MO, Hadid R, Daneva T, Gaillard RC (1992) Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 131: 2430-2436. doi:10.1210/en.131.5.2430. PubMed: 1330501.
16. Hoekstra M, Kruijt JK, Van Eck M, Van Berkel TJ (2003) Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J Biol Chem 278: 25448-25453. doi:10.1074/jbc.M301189200. PubMed: 12704191. (Pubitemid 36835295)
17. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159. doi:10.1006/abio.1987.9999. PubMed: 2440339. (Pubitemid 17064313)
18. Silvennoinen R, Escola-Gil JC, Julve J, Rotllan N, Llaverias G et al. (2012) Acute psychological stress accelerates reverse cholesterol transport via corticosterone-dependent inhibition of intestinal cholesterol absorption. Circ Res 111: 1459-1469. doi:10.1161/CIRCRESAHA.112.277962. PubMed: 22931956.
19. Baschant U, Lane NE, Tuckermann J (2012) The multiple facets of glucocorticoid action in rheumatoid arthritis. Nat Rev Rheumatol 8: 645-655. doi:10.1038/nrrheum.2012.166. PubMed: 23045254.
20. Luijten RK, Fritsch-Stork RD, Bijlsma JW, Derksen RH (2013) The use of glucocorticoids in Systemic Lupus Erythematosus. After 60 years still more an art than science. Autoimmun Rev 12: 617-628. doi:10.1016/j.autrev.2012.12.001. PubMed: 23232124.
21. Sato Y, Suzuki H, Sato T, Suda T, Yoda T et al. (2010) The role of endogenous glucocorticoids in lymphocyte development in melanocortin receptor 2-deficient mice. Biochem Biophys Res Commun 403: 253-257. doi:10.1016/j.bbrc. 2010.11.002. PubMed: 21056545.
22. Andréau K, Lemaire C, Souvannavong V, Adam A (1998) Induction of apoptosis by dexamethasone in the B cell lineage. J Immunopharmacol 40: 67-76. doi:10.1016/S0162-3109(98)00034-4. (Pubitemid 28434955)
23. Purton JF, Monk JA, Liddicoat DR, Kyparissoudis K, Sakkal S et al. (2004) Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death. J Immunol 173: 3816-3824. PubMed: 15356129. (Pubitemid 39280744)
24. Stojić-Vukanić Z, Rauski A, Kosec D, Radojević K, Pilipović I et al. (2009) Dysregulation of T-cell development in adrenal glucocorticoid-deprived rats. Exp Biol Med (Maywood) 234: 1067-1074. doi:10.3181/0902-RM-63.
25. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270: 286-290. doi:10.1126/science.270. 5234.286. PubMed: 7569976.
26. Ensrud K, Grimm RH Jr (1992) The white blood cell count and risk for coronary heart disease. Am Heart J 124: 207-213. doi:10.1016/0002-8703(92)90942- O. PubMed: 1615807.
27. Nasir K, Guallar E, Navas-Acien A, Criqui MH, Lima JA (2005) Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002. Arterioscler Thromb Vasc Biol 25: 1966-1971. doi:10.1161/01.ATV.0000175296.02550.e4. PubMed: 15976323. (Pubitemid 41243470)
28. Rasouli M, Kiasari AM, Bagheri B (2007) Total and differential leukocytes counts, but not hsCRP, ESR, and five fractioned serum proteins have significant potency to predict stable coronary artery disease. Clin Chim Acta 377: 127-132. doi:10.1016/j.cca.2006.09.009. PubMed: 17067564. (Pubitemid 44908241)
29. Sweetnam PM, Thomas HF, Yarnell JW, Baker IA, Elwood PC (1997) Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 145: 416-421. doi:10.1093/oxfordjournals.aje.a009123. PubMed: 9048515. (Pubitemid 27084213)
30. Wheeler JG, Mussolino ME, Gillum RF, Danesh J (2004) Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 25: 1287-1292. doi:10.1016/j.ehj.2004.05.002. PubMed: 15288155. (Pubitemid 38998504)
31. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G (2006) Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91: 4849-4853. doi:10.1210/jc.2006-0076. PubMed: 16968806. (Pubitemid 44917317)
32. Preusch MR, Rattazzi M, Albrecht C, Merle U, Tuckermann J et al. (2008) Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis. Arterioscler Thromb Vasc Biol 28: 2158-2164. doi:10.1161/ATVBAHA.108.174128. PubMed: 18787189.
33. Clayton RN, Raskauskiene D, Reulen RC, Jones PW (2011) Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab 96: 632-642. doi:10.1210/jc.2010-1942. PubMed: 21193542.
34. Mills EJ, Wu P, Chong G, Ghement I, Singh S et al. (2011) Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM 104: 109-124. doi:10.1093/qjmed/hcq165. PubMed: 20934984.
35. Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M et al. (2005) 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med 202: 517-527. doi:10.1084/jem.20050119. PubMed: 16103409. (Pubitemid 41186950)
36. Nuotio-Antar AM, Hachey DL, Hasty AH (2007) Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. Am J Physiol Endocrinol Metab 293: E1517-E1528. doi:10.1152/ajpendo.00522.2007. PubMed: 17878220. (Pubitemid 350255101)